Prothena Corporation plc

Last updated September 27, 2026

Organization details

Legal name
Prothena Corporation plc
Former names
Neotope Corp Ltd
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Ireland
Headquarters city
Dublin 2
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PRTA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001559053

Board of directors

Chief executives

Gene G. Kinney · President and CEO
Dates unknown

Director election results

Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Prothena Corporation plc's board connections Aktis Oncology Inc. Aktis Oncology Inc. Alkermes plc Alkermes plc Nuvation Bio Inc. Nuvation Bio Inc. Structure Therapeutics Inc. Structure Therapeutics... Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceuti... Daniel G. Welch Daniel G. Welch Helen Susan Kim Helen Susan Kim Shane Cooke Shane Cooke Prothena Corporation plc
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$12,349,447
18 purchases by 1 insider
Sold, last 12 months
$135,927
2 sales by 2 insiders
Date Insider Transaction Shares Price Value
Nov 9, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +140,000 $8.53 $1,194,158
Nov 6, 2026 SCULLY WILLIAM P 10% owner Gift −916,444 — —
Oct 27, 2026 SCULLY WILLIAM P 10% owner Gift +566,444 — —
Oct 23, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +50,000 $8.07 $403,525
Oct 22, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +100,000 $8.19 $818,520
Oct 8, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +90,000 $8.57 $770,904
Oct 7, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +125,000 $8.40 $1,050,150
Oct 2, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +100,000 $8.57 $857,240
Sep 29, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +162,000 $8.68 $1,406,160
Sep 28, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +103,500 $8.60 $890,100
Sep 18, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +100,000 $8.43 $843,000
Sep 2, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +27,000 $9.47 $255,690
Aug 20, 2026 SCULLY WILLIAM P 10% owner Open-market purchase +50,000 $8.79 $439,500
Aug 18, 2026 SCULLY WILLIAM P 10% owner Gift −627,553 — —
Aug 17, 2026 SCULLY WILLIAM P 10% owner Gift +336,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Prothena Corporation plc

Who is the CEO of Prothena Corporation plc?

Gene G. Kinney is Prothena Corporation plc's President and CEO.

How many directors are on Prothena Corporation plc's board?

Prothena Corporation plc's board has 10 directors: Daniel G. Welch, Dennis J. Selkoe, Gene G. Kinney, Helen Susan Kim, Karl Anders Olof Harfstrand, Lars Ekman, Paula K. Cobb, Richard T. Collier, Shane Cooke and William H. Dunn Jr.

Are Prothena Corporation plc insiders buying or selling shares?

Over the last 12 months, Prothena Corporation plc insiders bought $12.3 million of shares in 18 purchases and sold $135,927 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="prothena-corporation-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.